The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy;Peut-on envisager une thérapie cellulaire autologue de la dystrophie musculaire facio-scapulo-humérale?

Bulletin de l'Academie Nationale de Medecine

Volumn 189, Issue 4, 2005, Pages 697-714

  Desnuelle, Claude ^a,b   Sacconi, Sabrina ^a,b   Marolleau, Jean Pierre ^c   Larghero, Jérôme ^c   Vilquin, Jean Thomas ^b   Monod Broca, Philippe ^d   Fardeau, Michel ^d   Binet, Jacques Louis ^d   Grosgogeat, Yves ^d  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b INSERM   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d Institut de Myologie ^*

Author keywords

Biological therapy; Cell differenciation; Muscular dystrophies

Indexed keywords

EID: 25144523092     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33546-0     Document Type: Article

References (39)

1. PADBERG G. - Facio scapulo humeral disease. The Netherlands, Leiden University 1982
2. TAWIL R. - Facioscapulohumeral Muscular Dystrophy. Curr. Neurol. Neurosci. Reports 2004, 4, 51-54.
3. WIJMEGA C., HEWITT JE., SANDKUIJL A., CLARK LN., WRIGHT TJ., DAUWERSE HG. et al. - Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy Nature Genet., 1992, 2, 26-30.
4. LEMMERS RJ., VAN DER MAAREL S., VAN DEUKETOM JC., VAN DER WIELEN MJ., DEIDDA G., DAUWERSE HG. et al. - Inter and intrachromosomal subtelomeric rearrangements on 4q35 : implications for facioscapulohumeral muscular dystrophy (FSHD) etiology an ddiagnosis. Hum. Mol. Genet., 1998, 7, 1207-1214.
5. TAWIL R., FORRESTER J., GRIGGS RC., MENDELL JR., KISSEL J., MCDERMOTT MP. et al. - Evidence for anticipation : an association of deletion size with severity in facioscapulohumeral muscular dystrophy. Ann. Neurol., 1996, 39, 744-748.
6. GABELLINI D., GREEN MR., TUPLER R. - Inappropriate gene activation in FSHD : a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell., 2002, 110, 339-348.
7. TUPLER R., GABELLINI D. - Molecular basis of facioscapulohumeral dystrophy. Cell. Mol. Life Sci., 2004, 61, 557-566.
8. MAURO A. - Satellite cell of skeletal muscle fibres J. Biophys. Biochem. Cytol., 1961, 9, 493-495.
9. WRIGHT WE. - Myoblast senescence in muscular dystrophy. Exp. Cell. Res., 1985, 157, 343-354.
10. VILQUIN JT., MAROLLEAU JP., TREMBLAY JP., ROBERT I., TERNAUX B. - Procédé d'obtention de populations cellulaires d'origine musculaire et utilisations. Brevet (007304) déposé en France le 7 Juin 2000 et aux USA le 16 Octobre 2000 sous l'égide de l'AP-HP, l'INSERM et l'AFM.
11. BELLES-ISLES M., ROY R., DANSEREAU G., GOULET M., ROY B., BOUCGARD JP., TREMBLAY JP. - Rapid selection of donor myoblast clones for musclar dystrophy therapy using cell surface expression of NCAM. Eur J. Histochem., 1993, 37, 375-380.
12. WEBSTER C., PAVLATH GK., PARKS DR., WALSH FS., BLAU HM. - Isolation of human myoblasts with the fluorescent- activated cell sorter. Exp. Cell Res., 1988, 174, 252-265.
13. ALLSOPP RC., VAZIRI H., PATTERSON C., GOLDSTEIN S., YOUNGLAI EV., FUTCHER AB. et al. - Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA, 1992, 89, 10114-10118.
14. DECARY S., HAMIDA CB., MOULY V., BARBET JP., HETATI F., BUTLER-BROWNE GS. - Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscl. Disord., 2000, 10, 113-120.
15. RENAULT V., THORNELL LE., ERIKSSON PO., BUTLER-BROWNE GS., MOULY V. - Regenerative potential of human skeletal muscle during aging. Aging Cell, 2002, 1, 132-139.
16. COOPER RN., IRINTCHEV A., DI SANTO JP., ZWEYER M., MORGAN JE., PARTRIDGE TA. et al. - A new immunodefficient mouse model for human myoblast transplantation. Hum. Gene Therapy, 2001, 12, 823-831.
17. KINOSHITA I., VILQUIN JT., GUERETTE B., ASSELIN I., ROY R., TREMBLAY JP. - Very efficient myoblat allotransplantation in mice under FK506 immunosuppression. Muscle Nerve, 1994, 17, 1407-1415.
18. LETOURNEL E., FARDEAU M., LYTLE JO., SERRAULT M., GOSSELIN RA. - Scapulothoracic arthrodesis for patients who have facioscapulohumeral muscular dystrophy. J. Bone Joint Surgery, 1990, 72, 78-84.
19. TAWIL R., MCDERMOTT MP., PANDYA S., KISSEL J., GRIGGS RC., and the FSHD-DY Group. - A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. Neurology, 1997, 48, 46-49.
20. WALTER MC., LOCHMULLER H., REILICH P., KLOPSTOCK T., HUBERT R., HARTARD M. et al. - Creatine monohydrate in muscular dystrophies : a double blind placebo controlled clinical study. Neurology, 2000, 54, 1848-1850.
21. VAN DEN KOOI EL., VOGELS OJ., VAN ASSELDONK RJ., LINDEMAN E., HENDR JC., WOHLGEMUT M. et al. - Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology, 2004, 63, 702-708.
22. DELL'AGNOLA C., WANG Z., STORB R., TAPSCOTT SJ., KUHR CS., HAUSCHKA SD. et al. - Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne Muscular Dystrophy dogs. Blood, 2004, 182, 4311-4318.
23. COSSU G. - Fusion of bone marrow derived stem cells with striated muscle may not be sufficient to activate gene expression. J. Clin. Invest., 2004, 114, 1540-1543.
24. PARTRIDGE TA., MORGAN JE., COULTON GR., HOFFMAN EP., KUNKEL LM. - Conversion of mdx myofibres from dystrophin-negative to dystrophine-positive by injection of normal myoblasts, Nature, 1989, 337, 176-179.
25. HUARD J., VERRAULT S., ROY R., TREMBLAY M., TREMBLAY JP. - High efficiency of muscle regeneration after human myoblats clone transplantation in SCID mice. J. Clin. Invest, 1994, 93, 586-599.
26. NEUMEYER AM., CROS D., MCKENNA-YASEK D., ZAWADSKA A., HOFFMAN EP., PEGORARO E. et al. - Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy Neurology, 1998, 51, 589-592.
27. ITO H., VILQUIN JT., SKUK D., ROY B., GOULET M., LILLE S. et al. - Myoblast transplantation in non dystrophic dog. Neuromuscul. Disord., 1998, 8, 95-110.
28. GUSSONI E., PAVLATH GK., LANCTOT AM., SHARLA KR., MILLER RG. et al. - Normal dystrophin transcripts detected in Duchenne musculare dystrophy patients after myoblats transplantation. Nature, 1992, 356, 435-438.
29. KARPATI G., AJDUKOVIC D., ARNOLD D., GLEDHILL RB., GUTTMANN R., HOLLAND P. et al. - Myoblast tranfer in Duchenne muscular dystrophy. Ann. Neurol., 1993, 34, 8-17.
30. LAW PK., GOODWIN TG., FANG Q., QUINLEY T., VASTAGH G., HALL T. et al. - Human gene therapy with myoblast transfer. Transplant. Proc., 1997, 29, 2234-2237.
31. MENASCHÉ P., HAGEGE AA., SCORSIN M., POUZET B., DESNOS M., DUBOC D. et al. - First successful clinical myoblast transplantation for heart failure. The Lancet, 2001, 357, 279-280.
32. MENASCHÉ P., HAGEGE AA., VILQUIN JT., DESNOS M., ABERGEL E., POUZET B., et al. - Autologous skeletal myoblast transplantation for sever post infarction left ventriular dysfunction. J. Am. Coll. Cardiol., 2003, 41, 1078-1083.
33. WESBSTER C., BLAU HM. - Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts : implications for cell and gene therapy. Somat. Cell Mol. Genet., 16, 557-565.
34. SKUK D., FURLING D., BOUCHARD JP., GOULET M., ROY B., LACROIX Y., et al. - Transplantation of human myoblasts in SCID mice as a potential muscular model of myotonic dystrophy. Neuropathol. Exp. Neurol., 1999, 58, 921-931.
35. WINOKUR ST., BARRETT K., MARTIN JH., FORRESTER JR., SIMON M., TAWIL R. et al. - Facioscapulohumeral dystrophy (FSHD) myoblasts demontrate increased susceptibility to oxidative stress. Neuromusc. Disorders, 2003, 13, 322-333.
36. RICHARD I., ROUDAUT C., MARCHAND S., BAGHDIGUIAN, HERASSE M., STOCKHOLM D. et al. - Loss of calpain3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated κβα/nuclear factor kappaβ pathway perturbation in mice. J. Cell. Biol., 2000, 151, 1583-1590.
37. SKUK D. - Myoblast transplantation for inherited myopathie : a clinical approach. Expert Opin. Biol. Ther., 2004, 4, 1871-1885.
38. SKUK D., ROY B., GOULET A., CHAPDELAINE P., BOUCHARD JP., ROY R. et al. - Dystrophin expression of myofibers of Duchenne muscular dystrophy patients following intra muscular injections of normal myogenic cells. Mol. Ther., 2004, 9, 475-482.
39. SKUK D., GOULET M., ROY B., TREMBLAY JP. - Efficacy of myoblast transplantation in whole muscle of non-human primates following simple intramuscular injections : toward defining strategies applicable to humans Exp. Neurol., 2002, 175, 112-126.